Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Minimum inhibitory concentration result"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ronald N. Jones, Gary E. Zurenko
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 17:313-316
The cross-resistance or cross-susceptibility of cefpodoxime and ceftriaxone for 3700 strains of Enterobacteriaceae, oxacillin-susceptible staphylococci, Streptococcus spp., Haemophilus influenzae, Moraxella catarrhalis, and Neisseria gonorrhoeae was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::967155c4c95a0bd63fd35b7a6ccf531b
https://doi.org/10.1016/0732-8893(93)90041-5
https://doi.org/10.1016/0732-8893(93)90041-5
Publikováno v:
Journal of Applied Microbiology. 127:693-700
Background Staphylococcus species are implicated in a wide range of community and hospital-acquired infections, which necessitates rapid provision of antibiotic susceptibility results for patients at risk. The current study evaluated the usefulness o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97917a3b52db8668645d808db838acf0
https://doi.org/10.1111/jam.14347
https://doi.org/10.1111/jam.14347
Autor:
Nobuaki Matsunaga, Shinya Tsuzuki, Keigo Shibayama, Motoyuki Sugai, Koji Yahara, Norio Ohmagari, Takayuki Akiyama
Publikováno v:
Open Forum Infectious Diseases
Background Penicillin is often recommended as the first choice for Streptococcus pneumoniae infection due to its effectiveness and narrow spectrum. However, it is not clear whether increased penicillin consumption at the population level induces peni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b2acee68503cc3d2fd9519ed5e73a7
https://doi.org/10.1093/ofid/ofaa439.277
https://doi.org/10.1093/ofid/ofaa439.277
28. Regulation of the Staphylococcal β-lactamase Plays a Major Role in the cefazolin Inoculum Effect
Autor:
Sara I Gomez-Villegas, An Q Dinh, Jinnethe Reyes, Diana Panesso-Botero, Maria I Reyes, Rafael Rios, Oscar Ortega-Recalde, Lorena Diaz, Sandra Rincon, Barbara E Murray, Kavindra V Singh, Cesar A Arias
Publikováno v:
Open Forum Infectious Diseases
Background Cefazolin (Cz) is commonly used to treat methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia. Yet, some MSSA isolates producing the staphylococcal β-lactamase (BlaZ) exhibit the Cz inoculum effect (CzIE), defined as an increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0528c4e2b74e8339a9f4c3c35c9d69eb
https://doi.org/10.1093/ofid/ofaa417.027
https://doi.org/10.1093/ofid/ofaa417.027
Autor:
Takayuki Katsube, Nao Kawaguchi, Yuko Matsunaga, Mari Ariyasu, Tsutae Den Nagata, Simon Portsmouth, David Paterson, Michael J Satlin, Markus Zeitlinger, Roger Echols, Toshihiro Wajima
Publikováno v:
Open Forum Infectious Diseases
Background Cefiderocol (CFDC), a novel siderophore cephalosporin, has demonstrated potent antibacterial activity against a wide range of Gram-negative bacteria including carbapenem-resistant strains. We aimed to evaluate relationships between drug ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0847125372888063166d3a95734d79eb
https://doi.org/10.1093/ofid/ofaa439.1498
https://doi.org/10.1093/ofid/ofaa439.1498
Autor:
Sudha Chaturvedi, Denise Dunbar, Dorothy F Baynham, Jill Fischer, Brendan R Jackson, Elizabeth L. Berkow, Meghan Lyman, Stephanie Gumbis, Michele Plehn, Diane Podzorski, Emily Schneider, Dawn M. Sievert, Shawn R. Lockhart, Kaitlin Forsberg
Publikováno v:
Open Forum Infectious Diseases
Background Many U.S. clinical laboratories lack capacity to definitively identify fungi or perform antifungal susceptibility testing (AFST). To expand testing access, CDC’s Antibiotic Resistance Laboratory Network (AR Lab Network) provides Candida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebca287929ca738072e9b69c197ae23b
https://doi.org/10.1093/ofid/ofaa439.465
https://doi.org/10.1093/ofid/ofaa439.465
Publikováno v:
Microbes & Infectious Diseases; Nov2024, Vol. 5 Issue 4, p1438-1449, 12p
Autor:
Scott K. Heysell, Paul G. Ambrose, Guy E. Thwaites, Pooi S Lee, Paula Bendet, Shashikant Srivastava, Tawanda Gumbo, Thearith Koeuth, Sujata M. Bhavnani, Devyani Deshpande, Jotam G. Pasipanodya, Stellah G. Mpagama
Background Levofloxacin is used for the treatment of multidrug-resistant tuberculosis; however the optimal dose is unknown. Methods We used the hollow fiber system model of tuberculosis (HFS-TB) to identify 0–24 hour area under the concentration-ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2ed17c47b4d8e40ec47dfc9b0c56ce
https://europepmc.org/articles/PMC6260169/
https://europepmc.org/articles/PMC6260169/
Publikováno v:
Open Forum Infectious Diseases
Background Candida auris is an emerging multidrug-resistant fungus that is rapidly spreading worldwide. In publications from India, it has already accounted for >5% of candidemia in a national survey of ICUs and as much as 30% of candidemia at indivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51dd73cc5051660400002a7c80aaa6ca
http://europepmc.org/articles/PMC6810388
http://europepmc.org/articles/PMC6810388